- Home
- FCEL vs VYGR Comparison
FCEL vs VYGR Comparison
Compare FCEL & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCEL
- VYGR
- Stock Information
- Founded
- FCEL 1969
- VYGR 2013
- Country
- FCEL United States
- VYGR United States
- Employees
- FCEL N/A
- VYGR N/A
- Industry
- FCEL Industrial Machinery/Components
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- FCEL Energy
- VYGR Health Care
- Exchange
- FCEL Nasdaq
- VYGR Nasdaq
- Market Cap
- FCEL 273.9M
- VYGR 231.9M
- IPO Year
- FCEL 1992
- VYGR 2015
- Fundamental
- Price
- FCEL $7.06
- VYGR $3.96
- Analyst Decision
- FCEL Hold
- VYGR Strong Buy
- Analyst Count
- FCEL 4
- VYGR 7
- Target Price
- FCEL $8.91
- VYGR $16.17
- AVG Volume (30 Days)
- FCEL 3.5M
- VYGR 500.5K
- Earning Date
- FCEL 12-18-2025
- VYGR 11-10-2025
- Dividend Yield
- FCEL N/A
- VYGR N/A
- EPS Growth
- FCEL N/A
- VYGR N/A
- EPS
- FCEL N/A
- VYGR N/A
- Revenue
- FCEL $152,472,000.00
- VYGR $31,316,000.00
- Revenue This Year
- FCEL $34.50
- VYGR N/A
- Revenue Next Year
- FCEL $25.64
- VYGR $107.10
- P/E Ratio
- FCEL N/A
- VYGR N/A
- Revenue Growth
- FCEL 78.81
- VYGR N/A
- 52 Week Low
- FCEL $3.58
- VYGR $2.65
- 52 Week High
- FCEL $13.98
- VYGR $7.44
- Technical
- Relative Strength Index (RSI)
- FCEL 42.76
- VYGR 34.88
- Support Level
- FCEL $6.98
- VYGR $4.03
- Resistance Level
- FCEL $7.76
- VYGR $4.39
- Average True Range (ATR)
- FCEL 0.81
- VYGR 0.26
- MACD
- FCEL -0.14
- VYGR -0.07
- Stochastic Oscillator
- FCEL 14.82
- VYGR 12.14
About FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products and electrolysis platforms that decarbonize power and produce hydrogen. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company operates in USA, South Korea, Europe and Canada. Majority of revenue is from USA and South Korea.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.